Clinical Trial Update: An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

View source ↗

Summary

An observational study in participants with Indolent Systemic Mastocytosis (ISM) is currently in recruitment. The sponsor is Blueprint Medicines Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Systemic Mastocytosis

Snippet

Sponsor: Blueprint Medicines Corporation | Conditions: Indolent Systemic Mastocytosis | Status: RECRUITING